Image: 侯波 | Public domain | via Wikimedia Commons
Biography
Ye Xiaoping, a prominent figure in China's pharmaceutical industry, is the chairman of Hangzhou Tigermed Consulting, one of the country's largest contract research organizations. With a Ph.D. from Oxford University and an EMBA from Peking University, Ye transitioned from an executive role at Swiss pharmaceutical giant Roche to become a successful entrepreneur. His career has focused on advancing pharmaceutical research and development, spearheading the growth of Tigermed, and contributing to the innovation within the healthcare sector. Ye's net worth is currently estimated at $1.5 billion as of March 22, 2026.
